- Location
G protein coupled receptors
"-
TM Platform Will Be Used to Screen for GPCR-Directed Allosteric Modulator Antibodies
Feb 14, 2014DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
-
The Study Was Published Online in Nature Chemistry on DEC. 15.
Jan 2, 2014Roughly 40 percent of all medications act on cells' G protein-coupled receptors (GPCRs). One of these receptors, beta 2 adrenergic receptor site (B2AR), naturally transforms between two base configurations; knowing the precise location of ...
Tags: G protein-coupled receptors, beta 2 adrenergic receptor site
-
New Technique Is a Major Advance in Exploring GPCRs
Jan 2, 2014Researchers have used one of the brightest X-ray sources on the planet to map the 3-D structure of an important cellular gatekeeper known as a G protein-coupled receptor, or GPCR, in a more natural state than possible before. The new ...
-
Micro-LED Devices Help Uncover Information in The Brain
Nov 15, 2013Wireless micro-LED devices are allowing researchers to use optogenetics to uncover information about molecular and cellular events in the brain that underlie stress, addiction and depression. To better understand and one day provide ...
Tags: Mico-LEDs, Sheds Light
-
USPTO Has Announced The Issuance of a New Patent and Patent Family by The United States
Nov 8, 2013Integral Molecular, a biotechnology company, has announced the issuance of a new patent and patent family by the United States Patent and Trademark Office (USPTO) covering the composition of matter for its Lipoparticle technology. This ...
Tags: Lipoparticle Technology, USPTO
-
Morphosys and Heptares to Develop Antibody Therapeutics Against GPCRs
Feb 20, 2013MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs). According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed ...
Tags: antibody therapeutics, Heptares Therapeutics, GPCR disease
-
Raybiotech Introduced a Peptoid Drug Candidate and Diagnostic Ligand Discovery Service
Sep 29, 2012RayBiotech, a developer of antibody and protein array technologies, has introduced a peptoid drug candidate and diagnostic ligand discovery service program. The new service platform, which is aimed at the identification of novel ligands ...
Tags: rayBiotech, peptoid, ligand, peptoid drug candidate